{"transactions":[{"id":797085,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:09:42.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001850520-26-000005","document":"wk-form4_1777594180.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000005/wk-form4_1777594180.xml","form_type":"4"}},{"id":833674,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-19T22:17:49.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":true,"shares":17342,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kishen Mehta 21 Family Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse and the spouse's sibling are co-trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":17342,"source":{"system":"sec-edgar","filing":"0001850520-26-000003","document":"wk-form4_1773958666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000003/wk-form4_1773958666.xml","form_type":"4"}},{"id":833673,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-19T22:17:49.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":false,"shares":17342,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5320,"source":{"system":"sec-edgar","filing":"0001850520-26-000003","document":"wk-form4_1773958666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000003/wk-form4_1773958666.xml","form_type":"4"}},{"id":981715,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T16:19:44.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the \"Funds\") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options.  The Funds, and Suvretta Capital Management, LLC (\"Suvretta Capital\"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000850","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000101297525000850/form4.xml","form_type":"4"}},{"id":1156314,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:13:54.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000044","document":"wk-form4_1746652427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000044/wk-form4_1746652427.xml","form_type":"4"}},{"id":1335826,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T18:48:27.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the \"Funds\") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options.  The Funds, and Suvretta Capital Management, LLC (\"Suvretta Capital\"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000106299324020503/form4.xml","form_type":"4"}},{"id":1530696,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:34:01.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003755","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003755/primarydocument.xml","form_type":"4"}},{"id":1904639,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T21:52:19.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":52906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 2, 2024 or (b) the date of the 2024  Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":52906,"derivative":{"exercise_price":13.2,"expiration_date":"2033-05-02","underlying":"Common Shares","underlying_shares":52906},"source":{"system":"sec-edgar","filing":"0001562180-23-003945","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023003945/primarydocument.xml","form_type":"4"}},{"id":2142531,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142530,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.86,"expiration_date":"2029-01-17","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142529,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":2.58,"expiration_date":"2029-12-18","underlying":"Common Shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142528,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":6502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.61,"expiration_date":"2031-06-15","underlying":"Common Shares","underlying_shares":6502},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142527,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":4119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142526,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":10000,"derivative":{"exercise_price":1.86,"expiration_date":"2029-01-17","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142525,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":7500,"derivative":{"exercise_price":2.58,"expiration_date":"2029-12-18","underlying":"Common Shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142524,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":6502,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":6502,"derivative":{"exercise_price":4.61,"expiration_date":"2031-06-15","underlying":"Common Shares","underlying_shares":6502},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142523,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":4119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":4119,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142522,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":11716,"price":7,"value":82012.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options."}],"balance_after":22662,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142521,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":10000,"price":1.86,"value":18600.0,"ownership":{"direct":true},"balance_after":34378,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142520,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":7500,"price":2.58,"value":19350.0,"ownership":{"direct":true},"balance_after":24378,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142519,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":6502,"price":4.61,"value":29974.22,"ownership":{"direct":true},"balance_after":16878,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142518,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":4119,"price":4.84,"value":19935.96,"ownership":{"direct":true},"balance_after":10376,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142517,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective as of the Distribution, each outstanding restricted share unit of RemainCo was adjusted so that such restricted share unit became a restricted share unit in respect of Common Shares (each, an \"Issuer RSU\") and a restricted share unit in respect of RemainCo common shares. At the effective time of the merger of a wholly owned subsidiary of Pfizer (\"Merger Sub\") with and into RemainCo pursuant to the Agreement and Plan of Merger, dated as of May 9, 2022, by and among RemainCo, Pfizer and Merger Sub, the Issuer RSUs accelerated and vested in full and were subsequently settled in Common Shares. As a result, the Reporting Person acquired restricted share units in respect of Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":6257,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2142516,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:39:41.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":5320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."}],"balance_after":5320,"source":{"system":"sec-edgar","filing":"0001562180-22-007081","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007081/primarydocument.xml","form_type":"4"}},{"id":2147582,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":36.64,"expiration_date":"2029-01-17","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2147581,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":50.85,"expiration_date":"2029-12-18","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2147580,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":13004,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":90.91,"expiration_date":"2031-06-15","underlying":"Common Shares","underlying_shares":13004},"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2147579,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":8239,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":95.33,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2147578,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2147577,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-03T20:27:51.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":10640,"price":148.5,"value":1580040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each common share of the Issuer (each, a \"Common Share\") outstanding immediately prior to the effective time of the Merger (other than certain excluded shares pursuant to the terms of the Merger Agreement), was converted into the right to receive the merger consideration in cash of $148.50, without interest, less any withholding taxes (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-006958","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022006958/primarydocument.xml","form_type":"4"}},{"id":2176271,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class B ordinary shares","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares, par value $0.0001 per share (each a \"Class B ordinary share\"), held by the reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), converted to the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on a one-for-one basis upon the consummation of the business combination between the Issuer and Akili Interactive Labs, Inc. (the \"Business Combination\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA I, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":6220000},"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2176270,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Common Stock","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"other","acquired":false,"shares":6860000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents the distribution for no consideration by the Sponsor of 6,860,000 shares of Common Stock to its members pro rata in accordance with their respective interests."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2176269,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Common Stock","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares, par value $0.0001 per share (each a \"Class B ordinary share\"), held by the reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), converted to the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on a one-for-one basis upon the consummation of the business combination between the Issuer and Akili Interactive Labs, Inc. (the \"Business Combination\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA I, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":6860000,"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2208132,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class B ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"exercise","acquired":false,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":6220000},"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2208131,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class A ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":6860000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents the distribution for no consideration by the Sponsor of 6,860,000 Class A ordinary shares to its members pro rata in accordance with their respective interests."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2208130,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class A ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"exercise","acquired":true,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":6860000,"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2287993,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-29T21:04:20.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":8239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":8239,"derivative":{"exercise_price":97.74,"expiration_date":"2032-04-27","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-003588","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022003588/primarydocument.xml","form_type":"4"}},{"id":2436946,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2022-01-12T21:04:57.000Z","date":"2022-01-10","kind":"exercise","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted 7,500 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":1875,"derivative":{"underlying":"Common Shares","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001562180-22-000436","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022000436/primarydocument.xml","form_type":"4"}},{"id":2436945,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-01-12T21:04:57.000Z","date":"2022-01-10","kind":"exercise","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10640,"source":{"system":"sec-edgar","filing":"0001562180-22-000436","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218022000436/primarydocument.xml","form_type":"4"}},{"id":2602530,"issuer":{"id":123913,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. IV","symbol":"DNAD"},"owners":[{"id":136266,"kind":"person","name":"SCS Sponsor IV LLC","position":1,"cik":"0001850376","reported_name":"SCS Sponsor IV LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136267,"kind":"person","name":"ChaChaCha DNA IV, LLC","position":5,"cik":"0001869773","reported_name":"ChaChaCha DNA IV, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:34:22.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor IV LLC forfeited at no cost 75,000 shares of Class B common stock of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor IV LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA IV, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869773/000120919121051683/doc4.xml","form_type":"4"}},{"id":2602531,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":5,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:31:25.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor III LLC forfeited at no cost 75,000 shares of Class B common stock of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA III, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919121051681/doc4.xml","form_type":"4"}},{"id":2602975,"issuer":{"id":125597,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. II","symbol":"DNAB"},"owners":[{"id":136272,"kind":"person","name":"SCS Sponsor II LLC","position":1,"cik":"0001850373","reported_name":"SCS Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136273,"kind":"person","name":"ChaChaCha DNA II, LLC","position":5,"cik":"0001869716","reported_name":"ChaChaCha DNA II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:28:29.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor II LLC forfeited at no cost 75,000 shares of Class B ordinary shares of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor II LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA II, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869716/000120919121051677/doc4.xml","form_type":"4"}},{"id":2602529,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":5,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:25:33.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor I LLC forfeited at no cost 75,000 shares of Class B ordinary shares of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA I, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919121051674/doc4.xml","form_type":"4"}},{"id":2639764,"issuer":{"id":123913,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. IV","symbol":"DNAD"},"owners":[{"id":136266,"kind":"person","name":"SCS Sponsor IV LLC","position":1,"cik":"0001850376","reported_name":"SCS Sponsor IV LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136267,"kind":"person","name":"ChaChaCha DNA IV, LLC","position":5,"cik":"0001869773","reported_name":"ChaChaCha DNA IV, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:56:37.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor IV LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA IV, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869773/000120919121045954/doc4.xml","form_type":"4"}},{"id":2639776,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":5,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:52:12.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers,\nChamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA III, LLC (\"ChaChaCha\"),\nwhich is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919121045953/doc4.xml","form_type":"4"}},{"id":2640119,"issuer":{"id":125597,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. II","symbol":"DNAB"},"owners":[{"id":136272,"kind":"person","name":"SCS Sponsor II LLC","position":1,"cik":"0001850373","reported_name":"SCS Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136273,"kind":"person","name":"ChaChaCha DNA II, LLC","position":5,"cik":"0001869716","reported_name":"ChaChaCha DNA II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:47:35.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor II LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA II, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869716/000120919121045951/doc4.xml","form_type":"4"}},{"id":2639767,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":5,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:42:58.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA I, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919121045949/doc4.xml","form_type":"4"}},{"id":2664131,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-06-17T21:51:47.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":13004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy. The common shares underlying this option vest in three equal installments on June 15, 2022, 2023, and 2024, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":13004,"derivative":{"exercise_price":93.21,"expiration_date":"2031-06-15","underlying":"Common Shares","underlying_shares":13004},"source":{"system":"sec-edgar","filing":"0001562180-21-004379","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000156218021004379/primarydocument.xml","form_type":"4"}}]}